2-86853008-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004931.5(CD8B):āc.482A>Gā(p.Glu161Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000911 in 1,536,166 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004931.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD8B | NM_004931.5 | c.482A>G | p.Glu161Gly | missense_variant | 3/6 | ENST00000390655.12 | NP_004922.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD8B | ENST00000390655.12 | c.482A>G | p.Glu161Gly | missense_variant | 3/6 | 1 | NM_004931.5 | ENSP00000375070 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000133 AC: 2AN: 150534Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000137 AC: 2AN: 146314Hom.: 0 AF XY: 0.0000257 AC XY: 2AN XY: 77768
GnomAD4 exome AF: 0.00000866 AC: 12AN: 1385632Hom.: 0 Cov.: 29 AF XY: 0.0000102 AC XY: 7AN XY: 683436
GnomAD4 genome AF: 0.0000133 AC: 2AN: 150534Hom.: 0 Cov.: 29 AF XY: 0.0000136 AC XY: 1AN XY: 73416
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 02, 2024 | The c.482A>G (p.E161G) alteration is located in exon 3 (coding exon 3) of the CD8B gene. This alteration results from a A to G substitution at nucleotide position 482, causing the glutamic acid (E) at amino acid position 161 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at